Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

˜The œLancet. Gastroenterology & hepatology

Topics

Medicine

Epidemiology

Pathology

Internal Medicine

Gastroenterology

Show all topics

DOI

10.1016/s2468-1253(16)30107-8